7-Oxa-2-azaspiro[3.5]nonane hydrochloride, 95.0%, 1g

6-Fluoro-3-oxo-3,4-dihydropyrazine-2-carbonitrile compound with dicyclohexylamine (1:1), 98%, 250mg

N-Methyl-tert-butylamine, 99.0%, 5g

1-Bromo-2-(difluoromethyl)benzene (stabilised over Potassium Carbonate), 97.0%, 100g

1-methyl-1H-indole-3-carbonitrile, 95.0%, 25g

(S)-(-)-2-Methyl-2-propanesulfinamide, min. 98%, 25 g, glass packaging

tert-butyl 5-oxo-1,4,9-triazaspiro[5.5]undecane-9-carboxylate, 95.0%, 500mg

(S)-3-Isobutylmorpholine, 95.0%, 250mg

1-(3,4-dichlorophenyl)-3-(ethoxycarbonyl)-4,5-dihydro-1H-pyrazole-5-carboxylic acid, 95.0%, 1g

5-Chloro-1H-pyrazole-4-carboxylic acid, 95.0%, 250mg

TERT-BUTYL 4-(4-(TRIFLUOROMETHOXY)BENZOYL)PIPERIDINE-1-CARBOXYLATE, 95.0%, 250mg

3-Bromophenylboronic Acid (contains varying amounts of Anhydride)1g

2,3,5,6-Tetrafluoro-4-(trifluoromethyl)benzenethiol>97.0%(GC)(T)5g